Proteomics identifies new therapeutic targets of early-stage hepatocellular carcinomaYing Jiang, Fuchu He, Aihua Sun et al.|Nature|2019Cited by 982
Zanidatamab for HER2-amplified, unresectable, locally advanced or metastatic biliary tract cancer (HERIZON-BTC-01): a multicentre, single-arm, phase 2b studyJames J. Harding, Sebastián Mondaca, Emerson Y. Chen et al.|The Lancet Oncology|2023Cited by 243
Distinct single-cell immune ecosystems distinguish true and de novo HBV-related hepatocellular carcinoma recurrencesShuling Chen, Ming Kuang, Cheng Huang et al.|Gut|2023Cited by 66
NT5DC2 promotes tumor cell proliferation by stabilizing EGFR in hepatocellular carcinomaKangshuai Li, Hui‐Chuan Sun|Cell Death and Disease|2020Cited by 59
MicroRNA-200a inhibits cell growth and metastasis by targeting Foxa2 in hepatocellular carcinomaShuying Chen, Hui‐Chuan Sun|Journal of Cancer|2017Cited by 33